Pancreatic cancer induces muscle wasting by promoting the release of pancreatic adenocarcinoma upregulated factor
활용도 Analysis
논문 Analysis
연구자 Analysis
'
Pancreatic cancer induces muscle wasting by promoting the release of pancreatic adenocarcinoma upregulated factor' 의 참고문헌
Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?
Understanding cachexia as a cancer metabolism syndrome
Understanding and managing cancer cachexia
The relevance of weight loss for survival and quality of life in patients with advanced gastrointestinal cancer treated with palliative chemotherapy
The IMPACT study : early loss of skeletal muscle mass in advanced pancreatic cancer patients
Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1
Refining procedures for the administration of substances. Report of the BVAAWF/FRAME/RSPCA/UFAW Joint Working Group on Refinement. British Veterinary Association Animal Welfare Foundation/Fund for the Replacement of Animals in Medical Experiments/Royal Society for the Prevention of Cruelty to Animals/Universities Federation for Animal Welfare
Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill
Protein degradation by the ubiquitin-proteasome pathway in normal and disease states
Protein breakdown in muscle wasting : role of autophagylysosome and ubiquitin-proteasome
Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer : a meta-analysis containing 8252 patients
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts : a population-based study
Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients
Pancreatic cancer related cachexia : influence on metabolism and correlation to weight loss and pulmonary function
Pancreatic adenocarcinoma upregulated factor, a novel endothelial activator, promotes angiogenesis and vascular permeability
Pancreatic adenocarcinoma upregulated factor promotes metastasis by regulating TLR/CXCR4 activation
Pancreatic adenocarcinoma up-regulated factor(PAUF)enhances the accumulation and functional activity of myeloid-derived suppressor cells(MDSCs)in pancreatic cancer
Pancreatic adenocarcinoma up-regulated factor(PAUF), a novel up-regulated secretory protein in pancreatic ductal adenocarcinoma
Pancreatic adenocarcinoma up-regulated factor has oncogenic functions in oral squamous cell carcinoma
Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the expression of β-catenin, leading to a rapid proliferation of pancreatic cells
Pancreas cancer-associated weight loss
PAUF promotes adhesiveness of pancreatic cancer cells by modulating focal adhesion kinase
PAUF functions in the metastasis of human pancreatic cancer cells and upregulates CXCR4 expression
Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology
MyD88 signalling is critical in the development of pancreatic cancer cachexia
Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia : an in vitro and in vivo study
Mechanisms regulating skeletal muscle growth and atrophy
Mechanisms of cancer cachexia
MAP3K11/GDF15 axis is a critical driver of cancer cachexia
Inhibition of protein synthesis alters protein degradation through activation of protein kinase B(AKT)
Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy
Inducible nitric oxide synthase(iNOS)in muscle wasting syndrome, sarcopenia, and cachexia
Impact of weight loss, appetite, and the inflammatory response on quality of life in gastrointestinal cancer patients
Immunomonitoring and prognostic relevance of neutrophils in clinical trials
Imaging body composition in cancer patients : visceral obesity, sarcopenia and sarcopenic obesity may impact on clinical outcome
GM-CSF rapidly primes mice for enhanced cytokine production in response to LPS and TNF
Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy
Estimation of cachexia among cancer patients based on four definitions
Elevation of cytokine levels in cachectic patients with prostate carcinoma
Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer
Elevated expression of pancreatic adenocarcinoma upregulated factor(PAUF)is associated with poor prognosis and chemoresistance in epithelial ovarian cancer
Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis
Curcumin prevents lipopolysaccharide-induced atrogin-1/MAFbx upregulation and muscle mass loss
Circulating monocyte chemoattractant protein-1(MCP-1)is associated with cachexia in treatment-naive pancreatic cancer patients
Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1/2 and p38 MAPKs
Chemotherapy-induced muscle wasting : association with NF-kappaB and cancer cachexia
Cancerassociated cachexia
Cancer cachexia: mediators, signaling, and metabolic pathways
Cancer cachexia and fatigue
Cancer cachexia : mechanisms and clinical implications
Cachexia in cancer patients
Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy
Anti-inflammatory therapies in cancer cachexia
Anabolic and catabolic pathways regulating skeletal muscle mass
Activity of the Akt-dependent anabolic and catabolic pathways in muscle and liver samples in cancer-related cachexia
A prospective study of the impact of weight loss and the systemic inflammatory response on quality of life in patients with inoperable non-small cell lung cancer
A PAUF-neutralizing antibody targets both carcinoma and endothelial cells to impede pancreatic tumor progression and metastasis
'
Pancreatic cancer induces muscle wasting by promoting the release of pancreatic adenocarcinoma upregulated factor'
의 유사주제(
